John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 15.21% |
| 3 | Industrials | 10.23% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Central Pacific Financial
CPF
$969M
| $964K | ﹤0.01% |
34,543
-25,595
| -43% | -$740K |
|
1702
Torrid Holdings
CURV
$209M
| $962K | ﹤0.01% |
158,736
+62,672
| +65% | +$534K |
|
|
GTY
1703
Getty Realty Corp
GTY
$2.08B
| $961K | ﹤0.01% |
33,575
+15,097
| +82% | +$436K |
|
1704
NBT Bancorp
NBTB
$2.67B
| $957K | ﹤0.01% |
26,485
-21,235
| -44% | -$825K |
|
1705
Alaska Air
ALK
$4.84B
| $956K | ﹤0.01% |
16,474
-145,052
| -90% | -$7.91M |
|
1706
Owens Corning
OC
$11.6B
| $949K | ﹤0.01% |
10,367
-129,726
| -93% | -$11.9M |
|
1707
Donegal Group Class A
DGICA
$710M
| $947K | ﹤0.01% |
70,583
+35,279
| +100% | +$493K |
|
1708
Century Casinos
CNTY
$35.7M
| $944K | ﹤0.01% |
78,977
-36,533
| -32% | -$414K |
|
1709
H.B. Fuller
FUL
$3.07B
| $944K | ﹤0.01% |
14,289
+7,904
| +124% | +$557K |
|
|
ACCD
1710
DELISTED
Accolade Inc
ACCD
| $944K | ﹤0.01% |
53,764
-392,963
| -88% | -$7.23M |
|
1711
Artivion
AORT
$1.29B
| $941K | ﹤0.01% |
43,995
-5,746
| -12% | -$111K |
|
|
OCFT
1712
DELISTED
OneConnect Financial Technology
OCFT
| $941K | ﹤0.01% |
66,714
-87,813
| -57% | -$1.55M |
|
1713
Tradeweb Markets
TW
$22.7B
| $940K | ﹤0.01% |
10,700
-44,598
| -81% | -$3.87M |
|
|
MTLS
1714
Materialise
MTLS
$374M
| $937K | ﹤0.01% |
48,443
-139,051
| -74% | -$2.8M |
|
1715
Spire Global
SPIR
$558M
| $936K | ﹤0.01% |
55,710
-1,238
| -2% | -$24.2K |
|
1716
PMV Pharmaceuticals
PMVP
$69.5M
| $935K | ﹤0.01% |
44,900
-226,646
| -83% | -$4M |
|
|
CYPH
1717
Cypherpunk Technologies Inc
CYPH
$177M
| $934K | ﹤0.01% |
53,375
-98,330
| -65% | -$2.1M |
|
1718
Radiant Logistics
RLGT
$403M
| $933K | ﹤0.01% |
146,398
-124,881
| -46% | -$827K |
|
|
TIGR
1719
UP Fintech Holding
TIGR
$976M
| $933K | ﹤0.01% |
190,315
-2,744,254
| -94% | -$12.3M |
|
1720
Frontdoor
FTDR
$5.75B
| $932K | ﹤0.01% |
31,219
-205,799
| -87% | -$6.86M |
|
1721
MiMedx Group
MDXG
$633M
| $932K | ﹤0.01% |
197,939
-74,056
| -27% | -$362K |
|
1722
Stepan Co
SCL
$1.41B
| $930K | ﹤0.01% |
+9,411
| New | +$1.02M |
|
1723
AvePoint
AVPT
$2.77B
| $928K | ﹤0.01% |
176,372
-293,952
| -62% | -$1.68M |
|
|
IDEX
1724
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $927K | ﹤0.01% |
+6,620
| New | +$845K |
|
1725
Daktronics
DAKT
$923M
| $925K | ﹤0.01% |
240,854
-17,849
| -7% | -$81.9K |
|
Similar funds
John Overdeck's Q1 2022 Portfolio in Review
As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John Overdeck opened a new position in Cisco worth $223M.
- John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
- John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
- John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.